1
|
Marty M, Chiaverini C, Milon C, Costa-Mendes L, Kémoun P, Mazereeuw-Hautier J, Joseph C. Perception of Oral Health-Related Quality of Life in Children with Epidermolysis Bullosa: A Quantitative and Qualitative Study. JDR Clin Trans Res 2023; 8:349-355. [PMID: 35993264 DOI: 10.1177/23800844221118362] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
KNOWLEDGE TRANSFER STATEMENT The results of this study confirm the difficulties experienced by patients in the oral sphere. They also show that patients are able to adapt and that their demands go beyond functional rehabilitation. This work should encourage dental practitioners to be part of the overall management of the disease, involving regular checkups, preventive dental measures, and oral hygiene education. Therefore, more effective communication is required, not only between the dental and dermatological teams but also with the parents and caregivers.
Collapse
Affiliation(s)
- M Marty
- Universite Toulouse III Paul Sabatier, Toulouse, France
| | - C Chiaverini
- University Hospital Centre Nice, Nice, Provence-Alpes-Côte d'Azu, France
| | - C Milon
- University Paul Sabatier Toulouse III Faculty of Dental Surgery, Toulouse, Midi-Pyrénées, France
| | - L Costa-Mendes
- University Paul Sabatier Toulouse III Faculty of Dental Surgery, Toulouse, Midi-Pyrénées, France
| | - P Kémoun
- University Paul Sabatier Toulouse III Faculty of Dental Surgery, Toulouse, Midi-Pyrénées, France
| | | | - C Joseph
- University of Cote d'Azur, Nice, France
| |
Collapse
|
2
|
Joseph C, Thurston C, Nizeyimana E, Scriba E, Conradsson DM, Rhoda A. Prevalence of secondary health conditions and mental status in persons with long-term spinal cord injury in South Africa: Comparison between public and private healthcare sectors. S Afr Med J 2023; 113:46-53. [PMID: 37170601 DOI: 10.7196/samj.2023.v113i5.16791] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2023] [Indexed: 05/13/2023] Open
Abstract
BACKGROUND Spinal cord injuries typically result in a range of negative health outcomes and health states, which impacts overall functioning, health and well-being. It remains important to establish the prevalence (burden) of health outcomes to help with the development of optimal treatment strategies. OBJECTIVES To determine the prevalence and treatment rates of secondary health conditions (SHCs) and mental health states in persons with long-term spinal cord injury (SCI) receiving public compared with private healthcare services in South Africa. METHODS A cross-sectional survey included 200 community-dwelling persons with long-term SCI, 60% with paraplegia, 53% with complete injuries and 156 from the public and 44 from private healthcare sectors. The following modules of the International Spinal Cord Injury (InSCI) community survey were used: (i) demographic and injury characteristics; (ii) SHCs and treatment rates; and (iii) vitality and emotional well-being. All statistical analyses were stratified according to healthcare sector. RESULTS Pain (47% v. 57), sexual dysfunction (59% v. 41%) and muscle spasms (54% v. 43%) were the most common SHCs in both cohorts, and the period prevalence was significantly higher for sleeping problems (41% v. 25%), sexual dysfunction (59% v. 41%) and contractures (42% v. 20%) in the public compared with the private cohort. Persons with SCI in the private cohort received treatment more often for sleeping problems (100% v. 45%), autonomic dysreflexia (75% v. 27%) and pain (56% v. 33%) than their counterparts with public insurance. Negative mental health states were prevalent in both groups. CONCLUSION SHCs and negative mental health were common in persons with SCI in South Africa, while those with public insurance reporter a higher occurrence of sleep problems and contractures, as well as lower treatment rates. Overall, a need exists to better support persons with SCI in the long-term context to facilitate improved functioning and wellbeing.
Collapse
Affiliation(s)
- C Joseph
- Department of Health and Rehabilitation Sciences; Division of Physiotherapy; Stellenbosch University; Cape Town.
| | - C Thurston
- Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Sweden.
| | - E Nizeyimana
- Department of Health and Rehabilitation Sciences, Division of Physiotherapy, Stellenbosch University, Cape Town, South Africa.
| | - E Scriba
- Spescare Medical Facility, Stellenbosch, Cape Town.
| | - D M Conradsson
- Women's Health and Allied Health Professionals Theme, Medical Unit Occupational Therapy and Physiotherapy, Karolinska University Hospital, Stockholm, Sweden.
| | - A Rhoda
- Deanery, Faculty of Community and Health Sciences, University of the Western Cape, Cape Town, South Africa.
| |
Collapse
|
3
|
Day C, Deetlefs M, O'Brien A, Smith J, Boyd M, Embling N, Patel S, Moody K, Ramabele T, Budge A, Tarwa T, Jim O, Maharaj T, Pandy S, Abrahams JM, Panieri A, Verhage S, Van der Merwe M, Geragotellis A, Amanjee W, Joseph C, Zhao Z, Moosa S, Bunting M, Pulani Y, Mukhari P, De Paiva M, Deyi G, Wonkam RP, Mancotywa N, Dunge A, Msimanga T, Singh A, Monnaruri O, Molale B, Butler TAG, Browde K, Muller C, Van der Walt J, Whitelaw R, Cronwright D, Sinha S, Binase U, Francis I, Boakye D, Dlamini S, Mendelson M, Peter J. Self-reported beta-lactam allergy in government and private hospitals in Cape Town, South Africa. S Afr Med J 2023; 113:69-74. [PMID: 36757070 DOI: 10.7196/samj.2023.v113i2.16760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2023] [Indexed: 02/10/2023] Open
Abstract
BACKGROUND Up to a quarter of inpatients in high-income countries (HICs) self-report beta-lactam allergy (BLA), which if incorrect,increases the use of alternative antibiotics, worsening individual health outcomes and driving bacterial resistance. In HICs, up to 95% ofself-reported BLAs are incorrect. The epidemiology of BLA in low- and middle-income African countries is unknown. OBJECTIVES To describe the epidemiology and de-labelling outcomes of self-reported BLA in hospitalised South African (SA) patients. METHODS Point-prevalence surveys were conducted at seven hospitals (adult, paediatric, government and privately funded, district andtertiary level) in Cape Town, SA, between April 2019 and June 2021. Ward prescription records and in-person interviews were conductedto identify and risk-stratify BLA patients using the validated PEN-FAST tool. De-labelling was attempted at the tertiary allergy clinic atGroote Schuur Hospital. RESULTS A total of 1 486 hospital inpatients were surveyed (1 166 adults and 320 children). Only 48 patients (3.2%) self-reported a BLA,with a higher rate in private than in government-funded hospitals (6.3% v. 2.8%; p=0.014). Using the PEN-FAST tool, only 10.4% (n=5/48)of self-reported BLA patients were classified as high risk for true penicillin hypersensitivity. Antibiotics were prescribed to 70.8% (n=34/48)of self-reported BLA patients, with 64.7% (n=22/34) receiving a beta-lactam. Despite three attempts to contact patients for de-labelling atthe allergy clinic, only 3/36 underwent in vivo testing, with no positive results, and 1 patient proceeded to a negative oral challenge. CONCLUSION Unlike HICs, self-reported BLA is low among inpatients in SA. The majority of those who self-reported BLA were low risk fortype 1 hypersensitivity, but outpatient de-labelling efforts were largely unsuccessful.
Collapse
Affiliation(s)
- C Day
- Division of Allergology and Clinical Immunology, Department of Medicine, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, South Africa.
| | - M Deetlefs
- Division of Allergology and Clinical Immunology, Department of Medicine, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, South Africa.
| | - A O'Brien
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - J Smith
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - M Boyd
- Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.
| | - N Embling
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - S Patel
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - K Moody
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - T Ramabele
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - A Budge
- Department of Paediatrics, Faculty of Health Sciences, University of Cape Town, South Africa.
| | - T Tarwa
- Molecular Mycobacteriology Research Unit, Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, South Africa.
| | - O Jim
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - T Maharaj
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - S Pandy
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - J-M Abrahams
- Division of Allergology and Clinical Immunology, Department of Medicine, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, South Africa.
| | - A Panieri
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - S Verhage
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - M Van der Merwe
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - A Geragotellis
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - W Amanjee
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - C Joseph
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - Z Zhao
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - S Moosa
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - M Bunting
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - Y Pulani
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - P Mukhari
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - M De Paiva
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - G Deyi
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - R P Wonkam
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - N Mancotywa
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - A Dunge
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - T Msimanga
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - A Singh
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - O Monnaruri
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - B Molale
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - T A G Butler
- Department of Paediatrics, Faculty of Health Sciences, University of Cape Town, South Africa.
| | - K Browde
- Division of Allergology and Clinical Immunology, Department of Paediatrics, Red Cross War Memorial Children's Hospital and Faculty of Health Sciences, University of Cape Town, South Africa.
| | - C Muller
- Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa.
| | - J Van der Walt
- Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa.
| | - R Whitelaw
- Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.
| | - D Cronwright
- Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.
| | - S Sinha
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - U Binase
- Faculty of Health Sciences, University of Cape Town, South Africa.
| | - I Francis
- Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.
| | - D Boakye
- Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.
| | - S Dlamini
- Division of Infectious Diseases and HIV Medicine, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.
| | - M Mendelson
- Division of Infectious Diseases and HIV Medicine, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.
| | - J Peter
- Division of Allergology and Clinical Immunology, Department of Medicine, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, South Africa; Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa.
| |
Collapse
|
4
|
Ishak R, Todter E, Sitarik A, Kim H, Joseph C, Johnson C, Ownby D, Eapen A. EARLY CHILDHOOD ATOPIC PHENOTYPES AND THE DEVELOPMENT OF ALLERGIC RESPIRATORY DISEASE. Ann Allergy Asthma Immunol 2022. [DOI: 10.1016/j.anai.2022.08.713] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
5
|
Oueiss A, Camia J, Masucci C, Charavet C, Joseph C. Exploring the mylohyoid area as a reference for three-dimensional digital mandibular superimposition. J Stomatol Oral Maxillofac Surg 2022; 123:672-676. [PMID: 35907610 DOI: 10.1016/j.jormas.2022.07.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/04/2022] [Revised: 07/19/2022] [Accepted: 07/22/2022] [Indexed: 11/15/2022]
Abstract
INTRODUCTION the quantification of tooth movements should be obtained at different specific times and compared at different stages for every orthodontic treatment. These movements are generally measured on teleradiographs or casts. The use of Cone Beam Computed tomography (CBCT) for maxillary superimposition is clearly established in the literature, but not well defined for mandibular superimposition. This study aims to explore and evaluate the accuracy of the mylo-hyoid area as a reference for mandibular Digital Dental Cast (DDC) three-dimensional (3D) superimposition. MATERIALS AND METHODS the study compared mandibular 3D overlays with profile teleradiographs in 30 patients followed at Nice Saint Roch University Hospital. The molar and incisor coordinates on the 3D superimposition based on the mylo-hyoid area were compared to the ones on the 2D lateral cephalogram. Differences between the two methods of superimposition were assessed using paired t-tests. RESULTS No statistically significant difference was observed between the lateral cephalogram-based and mandibular DDC superimposition methods in 3D sagittal and vertical displacements of the lower first molars and central incisors. CONCLUSION The study showed the mylo-hyoid area to be an accurate superimposition landmark for the 3D evaluation of mandibular orthodontic tooth displacement. This method is also applicable for patients with conventional orthodontic treatment records. Other studies should be conducted on larger populations, subgroups (malocclusions, therapeutics) and on the use of an intra-oral camera.
Collapse
Affiliation(s)
- A Oueiss
- Nice University Hospital, France; Côte d'Azur University, Nice, France; Department of orthodontics and dentofacial orthopedics, faculty of dentistry, Nice, France.
| | - J Camia
- Nice University Hospital, France; Côte d'Azur University, Nice, France; Department of orthodontics and dentofacial orthopedics, faculty of dentistry, Nice, France
| | - C Masucci
- Nice University Hospital, France; Côte d'Azur University, Nice, France; Department of orthodontics and dentofacial orthopedics, faculty of dentistry, Nice, France
| | - C Charavet
- Nice University Hospital, France; Côte d'Azur University, Nice, France; Department of orthodontics and dentofacial orthopedics, faculty of dentistry, Nice, France; UPR 7354 MICORALIS laboratory, Nice, France
| | - C Joseph
- Nice University Hospital, France; Côte d'Azur University, Nice, France; Department of orthodontics and dentofacial orthopedics, faculty of dentistry, Nice, France; Department of pediatric dentistry, faculty of dentistry, Nice, France; UPR 7354 MICORALIS laboratory, Nice, France
| |
Collapse
|
6
|
Joseph C, Willms D, Francisco G, Ruppert A, Athill C. Significant procedure length reduction when utilizing active esophageal cooling – a six-year single center study. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
A number of factors can influence procedure duration of left atrial ablation for the treatment of atrial fibrillation (AF). In addition to ablation techniques, the use of auxiliary tools such as intraoperative fluoroscopy and luminal esophageal temperature (LET) monitoring may impact procedure duration. However, unlike recent trends toward zero-fluoroscopy procedures, there has not been a widespread transition to alternative means of esophageal protection. Multi sensor LET monitoring leads to frequent pauses during ablations when dangerous esophageal temperatures have been reached. Although an increased risk of esophageal injury when utilizing LET monitoring as compared to active esophageal cooling has been suggested in recent studies, the degree to which LET monitoring impacts procedure duration has not been well documented. Consequently, we aimed to compare procedure duration in a large single center before and after active esophageal cooling was implemented in place of LET monitoring.
Objective
Review procedural timing data at a single large hospital before and after the implementation of active esophageal cooling in place of LET monitoring, and compare differences in procedure duration.
Methods
Using an existing hospital registry of ablation procedures, we obtained procedure durations for left atrial ablations for AF before and after the implementation of active esophageal cooling into the hospital protocol. Data was collected with IRB approval from a single hospital from January 2015 through November 2021. Prior to September 2018, multi-sensor LET monitoring was utilized in all patients, whereas all patients afterwards were treated with active esophageal cooling.
Results
Data was analyzed from a total of 412 patients. LET monitoring was utilized with 176 patients, while active esophageal cooling was utilized with 236 patients. In the LET monitored group the median procedure length was 191 minutes with an interquartile range (IQR) of 91 minutes. In the actively cooled group, the median procedure length was 147 minutes with an IQR of 61 minutes. This represents a median difference of 44 minutes, or 23% of total procedure time (p<0.001).
Conclusion
When compared to LET monitoring, the use of active esophageal cooling is associated with a significant time savings in PVI procedures.
Funding Acknowledgement
Type of funding sources: Private company. Main funding source(s): Attune Medical
Collapse
Affiliation(s)
- C Joseph
- University of Texas Southwestern Medical Center , Dallas , United States of America
| | - D Willms
- Sharp Memorial Hospital , San Diego , United States of America
| | - G Francisco
- Sharp Memorial Hospital , San Diego , United States of America
| | - A Ruppert
- Sharp Memorial Hospital , San Diego , United States of America
| | - C Athill
- Sharp Memorial Hospital , San Diego , United States of America
| |
Collapse
|
7
|
Joseph C, Nazari J, Zagrodzky J, Sherman J, Zagrodzky W, Bailey S, Ro A, Fisher W, Metzl M. Esophageal cooling during ablation of persistent atrial fibrillation is associated with improved freedom from arrhythmia at one-year follow up. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.461] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
Various factors influence successful freedom from atrial arrhythmia after pulmonary vein isolation (PVI) with radiofrequency (RF) ablation for the treatment of atrial fibrillation (AF). Lesion transmurality and continuity (as measured by the Continuity Index) are two important factors, and these can be worsened by pauses in RF energy application due to esophageal overheating. Proactive esophageal cooling precludes the need for premature cessation of power, avoiding partially-formed lesions and the need to “hop-scotch” in the left atrium. The resulting improvement in lesion continuity may improve long-term freedom from atrial arrhythmia after PVI, particularly in patients with persistent AF, where more posterior wall ablation is often necessary.
Purpose
Determine differences in freedom from arrhythmia at one year between patients receiving LET monitoring and those receiving esophageal cooling during PVI for persistent AF.
Methods
We reviewed data from two healthcare systems for patient rhythm status at one-year follow up after PVI for the treatment of persistent or long-standing persistent AF. We then determined Kaplan-Meier estimates of freedom from arrhythmia (AF, atrial flutter, and atrial tachycardia), and compared these between patients receiving esophageal cooling and those treated with traditional LET monitoring.
Results
A total of 252 patients received PVI for persistent or long-standing persistent AF and had data available for review. Of these, 148 received LET monitoring (with either a single or multi-sensor temperature probe), and 104 received active cooling with a dedicated esophageal cooling device. Mean age and gender for each group was similar (67.2, range 21 to 88 years, 36% female for LET monitoring, and 67.8, range 32 to 89 years, 30% female for esophageal cooling). KM estimates for freedom from AF at the one-year follow-up were 44.2% for LET monitored patients and 79.3% for actively cooled patients (P=0.01).
Conclusions
Freedom from atrial arrhythmia at one-year after PVI for persistent AF is associated with significant improvement when using active esophageal cooling rather than LET monitoring.
Funding Acknowledgement
Type of funding sources: Private company. Main funding source(s): Attune Medical
Collapse
Affiliation(s)
- C Joseph
- University of Texas Southwestern Medical Center , Dallas , United States of America
| | - J Nazari
- NorthShore University Health System , Chicago , United States of America
| | - J Zagrodzky
- Texas cardiac Arrhythmia , Austin , United States of America
| | - J Sherman
- Washington University in St. Louis , St. Louis , United States of America
| | - W Zagrodzky
- Colorado College , Colorado Springs , United States of America
| | - S Bailey
- Texas cardiac Arrhythmia , Austin , United States of America
| | - A Ro
- NorthShore University Health System , Chicago , United States of America
| | - W Fisher
- NorthShore University Health System , Chicago , United States of America
| | - M Metzl
- NorthShore University Health System , Chicago , United States of America
| |
Collapse
|
8
|
Joseph C, Cooper J, Schricker A, Sala D, Woods C. Use of an active esophageal cooling device in zero-fluoroscopy settings without intracardiac echocardiography. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Active esophageal cooling is increasingly being utilized during radiofrequency (RF) ablation to achieve pulmonary vein isolation (PVI) for the treatment of atrial fibrillation (AF). In addition to data showing decreases in severe esophageal injury with active esophageal cooling, placement of a commercially available cooling device can be identified on intracardiac echocardiography (ICE), allowing implementation in zero-fluoroscopy settings. In the case of procedures that do not have ICE available, an alternative method to determine proper placement of an esophageal cooling device is needed in zero-fluoroscopy settings..
Purpose
To describe a large single-center approach to visualizing an active esophageal cooling device into a 3D mapping system.
Methods
We reviewed data on patients treated with RF ablation for PVI procedures over the time frame 1/1/2020 to 12/31/21. Active esophageal cooling was phased in towards the end of 2020. For all cases, transseptal puncture was performed with the use of transesophageal echocardiography (TEE). After successful transseptal puncture, the TEE probe was removed, and either a single-sensor LET probe or an active esophageal cooling device was placed. For the active cooling device, the distal tip was cut, and an SL-1 (0.032 inch, 150 cm length) guidewire was placed through the central lumen of the cooling device (used for gastric suctioning and enteral feeding). The guidewire was pinned via a pin block to the 3D mapping system (EnSite, Abbott). Unipolar configuration was used to generate a 3D map, which was then visualized during device placement. Placement was confirmed after visualizing the guidewire tip on the 3D map passing below the coronary sinus (Figure 1).
Results
A total of 417 cases were performed over the study timeframe. The mean age of patients was 65±10 years, and 40% were female. A total of 5 complications were recorded (3 pericardial effusions, 1 pseudoaneurysm, and 1 air embolism). A total of 156 patients received LET monitoring, and 261 received active esophageal cooling. The mean procedure length was 109±24 minutes for cases utilizing LET monitoring, and 93±11 minutes for cases utilizing active esophageal cooling. Visualization of the active esophageal cooling device on the cardiac mapping system was possible in all cases.
Conclusions
We describe here the largest series to date utilizing active esophageal cooling in a zero-fluoroscopy, zero-ICE setting. With increasing efforts to reduce fluoroscopy, this approach allows pursuit of zero-fluoroscopy even in systems without the availability of ICE, while maintaining procedural speed and safety.
Funding Acknowledgement
Type of funding sources: Private company. Main funding source(s): Attune Medical
Collapse
Affiliation(s)
- C Joseph
- University of Texas Southwestern Medical Center , Dallas , United States of America
| | - J Cooper
- University of Texas Southwestern Medical Center , Dallas , United States of America
| | - A Schricker
- Mills-Peninsula Medical Center , Burlingame , United States of America
| | - D Sala
- Mills-Peninsula Medical Center , Burlingame , United States of America
| | - C Woods
- Mills-Peninsula Medical Center , Burlingame , United States of America
| |
Collapse
|
9
|
Cooper J, Joseph C, Xiong T, Brar D, Kostov V, Kulstad E, Daniels J. Patient age, gender, and early outcome after PVI atrial ablation: analysis of a large regional database. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Demographics such as patient age and gender have been inconsistently found to be associated with outcome after ablation to achieve pulmonary vein isolation (PVI). A database created by the Dallas-Fort Worth Hospital Council (DFWHC) includes a collaboration of 90 member hospitals in North Texas reporting data on procedures, diagnoses, and discharges. All patients in this system can be followed longitudinally via unique identification number. The availability of this large, regional database offers opportunities to better characterize trends.
Objective
Characterize the association between age, gender, and 60-day outcome in patients receiving PVI over a 7-year time span.
Methods
Using the DFWHC database, all PVI procedures performed from January 2013 to December 2019 were identified. Follow up visits for this cohort of patients were then obtained, and outcomes recorded. Early mortalities (occurring less than 60 days from PVI), mean age and patient gender were determined for each of the groups and compared.
Results
A total of 11,880 unique PVI procedures were performed over this 7 year timeframe. Mean patient age was 64±10 years, with 66% male and 34% female. A total of 130 mortalities at any time after PVI occurred (1.1%), with 19 (0.16%) occurring within 60 days of the procedure. In multivariate analysis, the risk of 60-day mortality increased with year of procedure (OR 1.07, 95% CI 0.85 to 1.4) and female gender (OR 1.43, 95% CI 0.57 to 3.6), and decreased with age (OR 0.99, 95% CI 0.95 to 1.03); however no variable demonstrated statistically significant association with outcome.
Conclusions
Although trends towards increasing mortality over time and in female patients were seen, the total number of events remained low, and no statistically significant associations between age, gender, and early mortality were identified in this large regional database.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- J Cooper
- University of Texas Southwestern Medical Center , Dallas , United States of America
| | - C Joseph
- University of Texas Southwestern Medical Center , Dallas , United States of America
| | - T Xiong
- University of Texas Southwestern Medical Center , Dallas , United States of America
| | - D Brar
- University of Texas Southwestern Medical Center , Dallas , United States of America
| | - V Kostov
- University of Texas Southwestern Medical Center , Dallas , United States of America
| | - E Kulstad
- University of Texas Southwestern Medical Center , Dallas , United States of America
| | - J Daniels
- University of Texas Southwestern Medical Center , Dallas , United States of America
| |
Collapse
|
10
|
Joseph C, Francisco G, Ruppert A, Willms D, Nazari J, Fisher W, Ro A, Sherman J, Zagrodzky J, Bailey S, Zagrodzky W, Athill C, Metzl M. Arrhythmia recurrence reduction with an active esophageal cooling device during radiofrequency ablation. Europace 2022. [DOI: 10.1093/europace/euac053.096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
As the burden of atrial fibrillation continues to rise with an aging population, there have been contrasting positions on the efficacy of left atrial ablation. While ablation techniques have continued to improve over the past decades, arrhythmia recurrence rates must be further reduced given the burden of ablation on patients. Since continuity of lesion sets has been associated with greater lesion durability, it has been theorized that the use of active esophageal cooling may facilitate greater freedom from arrhythmia.
Purpose
In order to investigate the association between use of active esophageal cooling and arrhythmia recurrence, we performed a multicenter retrospective study of arrhythmia recurrence rates in patients that received active cooling and compared them to those that received luminal esophageal temperature (LET) monitoring.
Methods
In this study, follow up data were collected from patients that underwent pulmonary vein isolation (PVI) at three separate large medical centers. Data were contained in a prospective hospital registry, a prospective physician registry, or the electronic health record, depending on the center. For each patient included, we recorded whether their ablation utilized LET monitoring or active esophageal cooling, along with their rhythm status at 1-year follow up. Rhythm status at follow-up was determined by either electrocardiogram, Holter monitor, or wearable heart rate monitor. Kaplan-Meier (KM) curves were created for freedom-from-arrhythmia at one year comparing those in the LET monitoring group to those in the active cooling group.
Results
Follow up data were collected from 1035 patients. There were 560 patients that received LET monitoring during their original ablation, and 475 patients that underwent active esophageal cooling. KM estimates for freedom-from-arrhythmia at one year were 42% in the LET monitored group and 65% in the actively cooled group (P<.001).
Conclusion
In this large multicenter study, there is a significant increase in freedom-from-arrhythmia at one year follow-up among patients that received active esophageal cooling as compared to those that underwent LET monitoring.
Collapse
Affiliation(s)
- C Joseph
- University of Texas Southwestern Medical Center, Dallas, United States of America
| | - G Francisco
- Sharp Memorial, San Diego, United States of America
| | - A Ruppert
- Sharp Memorial, San Diego, United States of America
| | - D Willms
- Sharp Memorial, San Diego, United States of America
| | - J Nazari
- NorthShore University Health System, Chicago, United States of America
| | - W Fisher
- NorthShore University Health System, Chicago, United States of America
| | - A Ro
- NorthShore University Health System, Chicago, United States of America
| | - J Sherman
- NorthShore University Health System, Chicago, United States of America
| | - J Zagrodzky
- Texas cardiac Arrhythmia, Austin, United States of America
| | - S Bailey
- Texas cardiac Arrhythmia, Austin, United States of America
| | - W Zagrodzky
- Texas cardiac Arrhythmia, Austin, United States of America
| | - C Athill
- Sharp Memorial, San Diego, United States of America
| | - M Metzl
- NorthShore University Health System, Chicago, United States of America
| |
Collapse
|
11
|
Joseph C, Francisco G, Ruppert A, Willms D, Metzl M, Fisher W, Nazari J, Ro A, Zagrodzky J, Zagrodzky W, Sherman J, Bailey S, Athill C. Effect of a proactive esophageal cooling device on procedure length - a multicenter comparison of persistent and paroxysmal atrial fibrillation. Europace 2022. [DOI: 10.1093/europace/euac053.086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
During left atrial ablation for the treatment of atrial fibrillation (AF), effective esophageal protection is essential for reducing or preventing thermal injury. Traditional methods include luminal esophageal temperature (LET) monitoring that lead to frequent pauses in the procedure when temperature alarms alert operators to dangerous temperature levels. While there have been recent studies that demonstrate an association between active esophageal cooling and a reduction in procedure duration regardless of AF type, these retrospective studies have been conducted at single or joint centers which may lead to confounding from other time-saving variables that have changed over time.
Purpose
Consequently, we sought to perform a large-scale multicenter comparison to better elucidate the association between procedure length and the use of active cooling in patients with persistent and paroxysmal atrial fibrillation.
Methods
In this study, we collected data from three large hospital centers, one hospital-maintained registry, one physician-maintained registry, and one through EHR data review and aggregated in groups separated by AF type as well as whether the patients received active cooling or LET monitoring. We then compared median procedure durations in each group.
Results
There were a total of 753 patients included in this study. Of the 360 patients with paroxysmal AF, 179 received active esophageal cooling while 181 underwent LET monitoring. In the persistent AF group with 393 patients, 157 received active esophageal cooling and 236 underwent LET monitoring. Among patients with paroxysmal AF, the median mean procedure duration was 137 minutes in the LET monitored group, and 90 minutes in the actively cooled group with an overall reduction of 47 minutes (P<.001). In patients with persistent AF, the median procedure duration was 148 minutes in the LET monitored group and 94 minutes in the actively cooled group with an overall reduction of 54 minutes (P<.001). The relative reduction as a percent of total procedure time was 34%, and 36%, for paroxysmal and persistent AF cases, respectively.
Conclusion
In this large multicenter review, there is a significant reduction in procedure length when using active esophageal cooling, regardless of AF type.
Collapse
Affiliation(s)
- C Joseph
- University of Texas Southwestern Medical Center, Dallas, United States of America
| | - G Francisco
- Sharp Memorial, San Diego, United States of America
| | - A Ruppert
- Sharp Memorial, San Diego, United States of America
| | - D Willms
- Sharp Memorial, San Diego, United States of America
| | - M Metzl
- NorthShore University Health System, Chicago, United States of America
| | - W Fisher
- NorthShore University Health System, Chicago, United States of America
| | - J Nazari
- NorthShore University Health System, Chicago, United States of America
| | - A Ro
- NorthShore University Health System, Chicago, United States of America
| | - J Zagrodzky
- Texas cardiac Arrhythmia, Austin, United States of America
| | - W Zagrodzky
- Texas cardiac Arrhythmia, Austin, United States of America
| | - J Sherman
- NorthShore University Health System, Chicago, United States of America
| | - S Bailey
- Texas cardiac Arrhythmia, Austin, United States of America
| | - C Athill
- Sharp Memorial, San Diego, United States of America
| |
Collapse
|
12
|
Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, Anyaneji UJ, Bester PA, Boni MF, Chand M, Choga WT, Colquhoun R, Davids M, Deforche K, Doolabh D, du Plessis L, Engelbrecht S, Everatt J, Giandhari J, Giovanetti M, Hardie D, Hill V, Hsiao NY, Iranzadeh A, Ismail A, Joseph C, Joseph R, Koopile L, Kosakovsky Pond SL, Kraemer MUG, Kuate-Lere L, Laguda-Akingba O, Lesetedi-Mafoko O, Lessells RJ, Lockman S, Lucaci AG, Maharaj A, Mahlangu B, Maponga T, Mahlakwane K, Makatini Z, Marais G, Maruapula D, Masupu K, Matshaba M, Mayaphi S, Mbhele N, Mbulawa MB, Mendes A, Mlisana K, Mnguni A, Mohale T, Moir M, Moruisi K, Mosepele M, Motsatsi G, Motswaledi MS, Mphoyakgosi T, Msomi N, Mwangi PN, Naidoo Y, Ntuli N, Nyaga M, Olubayo L, Pillay S, Radibe B, Ramphal Y, Ramphal U, San JE, Scott L, Shapiro R, Singh L, Smith-Lawrence P, Stevens W, Strydom A, Subramoney K, Tebeila N, Tshiabuila D, Tsui J, van Wyk S, Weaver S, Wibmer CK, Wilkinson E, Wolter N, Zarebski AE, Zuze B, Goedhals D, Preiser W, Treurnicht F, Venter M, Williamson C, Pybus OG, Bhiman J, Glass A, Martin DP, Rambaut A, Gaseitsiwe S, von Gottberg A, de Oliveira T. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature 2022; 603:679-686. [PMID: 35042229 PMCID: PMC8942855 DOI: 10.1038/s41586-022-04411-y] [Citation(s) in RCA: 918] [Impact Index Per Article: 459.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2021] [Accepted: 01/07/2022] [Indexed: 01/02/2023]
Abstract
The SARS-CoV-2 epidemic in southern Africa has been characterized by three distinct waves. The first was associated with a mix of SARS-CoV-2 lineages, while the second and third waves were driven by the Beta (B.1.351) and Delta (B.1.617.2) variants, respectively1-3. In November 2021, genomic surveillance teams in South Africa and Botswana detected a new SARS-CoV-2 variant associated with a rapid resurgence of infections in Gauteng province, South Africa. Within three days of the first genome being uploaded, it was designated a variant of concern (Omicron, B.1.1.529) by the World Health Organization and, within three weeks, had been identified in 87 countries. The Omicron variant is exceptional for carrying over 30 mutations in the spike glycoprotein, which are predicted to influence antibody neutralization and spike function4. Here we describe the genomic profile and early transmission dynamics of Omicron, highlighting the rapid spread in regions with high levels of population immunity.
Collapse
Affiliation(s)
| | - Sikhulile Moyo
- Botswana Harvard AIDS Institute Partnership, Botswana Harvard HIV Reference Laboratory, Gaborone, Botswana
- Harvard T.H. Chan School of Public Health, Boston, MA, USA
- Botswana Presidential COVID-19 Taskforce, Gaborone, Botswana
| | - Daniel G Amoako
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
| | - Houriiyah Tegally
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - Cathrine Scheepers
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
- South African Medical Research Council Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Christian L Althaus
- Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
| | - Ugochukwu J Anyaneji
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - Phillip A Bester
- Division of Virology, National Health Laboratory Service, Bloemfontein, South Africa
- Division of Virology, University of the Free State, Bloemfontein, South Africa
| | - Maciej F Boni
- Center for Infectious Disease Dynamics, Department of Biology, Pennsylvania State University, University Park, PA, USA
| | | | | | - Rachel Colquhoun
- Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK
| | - Michaela Davids
- Zoonotic Arbo and Respiratory Virus Program, Centre for Viral Zoonoses, Department of Medical Virology, University of Pretoria, Pretoria, South Africa
| | | | - Deelan Doolabh
- Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
| | - Louis du Plessis
- Department of Zoology, University of Oxford, Oxford, UK
- Department of Biosystems Science and Engineering, ETH Zurich, Zurich, Switzerland
| | - Susan Engelbrecht
- Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town, South Africa
| | - Josie Everatt
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
| | - Jennifer Giandhari
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - Marta Giovanetti
- Laboratorio de Flavivirus, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil
- Laboratório de Genética Celular e Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | - Diana Hardie
- Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
- Division of Virology, NHLS Groote Schuur Laboratory, Cape Town, South Africa
| | - Verity Hill
- Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK
| | - Nei-Yuan Hsiao
- Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
- Division of Virology, NHLS Groote Schuur Laboratory, Cape Town, South Africa
- Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Cape Town, South Africa
| | - Arash Iranzadeh
- Division of Computational Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
| | - Arshad Ismail
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
| | | | - Rageema Joseph
- Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
| | - Legodile Koopile
- Botswana Harvard AIDS Institute Partnership, Botswana Harvard HIV Reference Laboratory, Gaborone, Botswana
| | - Sergei L Kosakovsky Pond
- Institute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, Philadelphia, PA, USA
| | | | - Lesego Kuate-Lere
- Health Services Management, Ministry of Health and Wellness, Gaborone, Botswana
| | - Oluwakemi Laguda-Akingba
- NHLS Port Elizabeth Laboratory, Port Elizabeth, South Africa
- Faculty of Health Sciences, Walter Sisulu University, Mthatha, South Africa
| | - Onalethatha Lesetedi-Mafoko
- Public Health Department, Integrated Disease Surveillance and Response, Ministry of Health and Wellness, Gaborone, Botswana
| | - Richard J Lessells
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - Shahin Lockman
- Botswana Harvard AIDS Institute Partnership, Botswana Harvard HIV Reference Laboratory, Gaborone, Botswana
- Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Alexander G Lucaci
- Institute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, Philadelphia, PA, USA
| | - Arisha Maharaj
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - Boitshoko Mahlangu
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
| | - Tongai Maponga
- Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town, South Africa
| | - Kamela Mahlakwane
- Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town, South Africa
- NHLS Tygerberg Laboratory, Tygerberg Hospital, Cape Town, South Africa
| | - Zinhle Makatini
- Department of Virology, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa
| | - Gert Marais
- Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
- Division of Virology, NHLS Groote Schuur Laboratory, Cape Town, South Africa
| | - Dorcas Maruapula
- Botswana Harvard AIDS Institute Partnership, Botswana Harvard HIV Reference Laboratory, Gaborone, Botswana
| | - Kereng Masupu
- Botswana Presidential COVID-19 Taskforce, Gaborone, Botswana
| | - Mogomotsi Matshaba
- Botswana Presidential COVID-19 Taskforce, Gaborone, Botswana
- Botswana-Baylor Children's Clinical Centre of Excellence, Gaborone, Botswana
- Baylor College of Medicine, Houston, TX, USA
| | - Simnikiwe Mayaphi
- Department of Medical Virology, University of Pretoria, Pretoria, South Africa
| | - Nokuzola Mbhele
- Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
| | - Mpaphi B Mbulawa
- National Health Laboratory, Health Services Management, Ministry of Health and Wellness, Gaborone, Botswana
| | - Adriano Mendes
- Zoonotic Arbo and Respiratory Virus Program, Centre for Viral Zoonoses, Department of Medical Virology, University of Pretoria, Pretoria, South Africa
| | - Koleka Mlisana
- National Health Laboratory Service (NHLS), Johannesburg, South Africa
- Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa
| | - Anele Mnguni
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
| | - Thabo Mohale
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
| | - Monika Moir
- Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
| | - Kgomotso Moruisi
- Health Services Management, Ministry of Health and Wellness, Gaborone, Botswana
| | - Mosepele Mosepele
- Botswana Presidential COVID-19 Taskforce, Gaborone, Botswana
- Department of Medicine, Faculty of Medicine, University of Botswana, Gaborone, Botswana
| | - Gerald Motsatsi
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
| | - Modisa S Motswaledi
- Botswana Presidential COVID-19 Taskforce, Gaborone, Botswana
- Department of Medical Laboratory Sciences, School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana
| | - Thongbotho Mphoyakgosi
- National Health Laboratory, Health Services Management, Ministry of Health and Wellness, Gaborone, Botswana
| | - Nokukhanya Msomi
- Discipline of Virology, School of Laboratory Medicine and Medical Sciences and National Health Laboratory Service (NHLS), University of KwaZulu-Natal, Durban, South Africa
| | - Peter N Mwangi
- Division of Virology, University of the Free State, Bloemfontein, South Africa
- Next Generation Sequencing Unit, Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
| | - Yeshnee Naidoo
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - Noxolo Ntuli
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
| | - Martin Nyaga
- Division of Virology, University of the Free State, Bloemfontein, South Africa
- Next Generation Sequencing Unit, Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
| | - Lucier Olubayo
- Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Cape Town, South Africa
- Division of Computational Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
| | - Sureshnee Pillay
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - Botshelo Radibe
- Botswana Harvard AIDS Institute Partnership, Botswana Harvard HIV Reference Laboratory, Gaborone, Botswana
| | - Yajna Ramphal
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - Upasana Ramphal
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - James E San
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - Lesley Scott
- Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, South Africa
| | - Roger Shapiro
- Botswana Harvard AIDS Institute Partnership, Botswana Harvard HIV Reference Laboratory, Gaborone, Botswana
- Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Lavanya Singh
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| | | | - Wendy Stevens
- Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, South Africa
| | - Amy Strydom
- Zoonotic Arbo and Respiratory Virus Program, Centre for Viral Zoonoses, Department of Medical Virology, University of Pretoria, Pretoria, South Africa
| | - Kathleen Subramoney
- Department of Virology, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa
| | - Naume Tebeila
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
| | - Derek Tshiabuila
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - Joseph Tsui
- Department of Zoology, University of Oxford, Oxford, UK
| | - Stephanie van Wyk
- Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
| | - Steven Weaver
- Institute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, Philadelphia, PA, USA
| | - Constantinos K Wibmer
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
| | - Eduan Wilkinson
- Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
| | - Nicole Wolter
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
- School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | | | - Boitumelo Zuze
- Botswana Harvard AIDS Institute Partnership, Botswana Harvard HIV Reference Laboratory, Gaborone, Botswana
| | - Dominique Goedhals
- Division of Virology, University of the Free State, Bloemfontein, South Africa
- PathCare Vermaak, Pretoria, South Africa
| | - Wolfgang Preiser
- Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town, South Africa
- NHLS Tygerberg Laboratory, Tygerberg Hospital, Cape Town, South Africa
| | - Florette Treurnicht
- Department of Virology, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa
| | - Marietje Venter
- Zoonotic Arbo and Respiratory Virus Program, Centre for Viral Zoonoses, Department of Medical Virology, University of Pretoria, Pretoria, South Africa
| | - Carolyn Williamson
- Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
- Division of Virology, NHLS Groote Schuur Laboratory, Cape Town, South Africa
- Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Cape Town, South Africa
- Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
| | | | - Jinal Bhiman
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
- South African Medical Research Council Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Allison Glass
- Lancet Laboratories, Johannesburg, South Africa
- Department of Molecular Pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Darren P Martin
- Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Cape Town, South Africa
- Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
| | - Andrew Rambaut
- Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK
| | - Simani Gaseitsiwe
- Botswana Harvard AIDS Institute Partnership, Botswana Harvard HIV Reference Laboratory, Gaborone, Botswana
- Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Anne von Gottberg
- National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
- School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Tulio de Oliveira
- KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
- Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
- Department of Global Health, University of Washington, Seattle, WA, USA.
| |
Collapse
|
13
|
Mabille C, El Samad Y, Joseph C, Brunschweiler B, Goeb V, Grados F, Lanoix JP. Medical versus surgical treatment in native hip and knee septic arthritis. Infect Dis Now 2022; 52:121. [PMID: 35063703 DOI: 10.1016/j.idnow.2022.01.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Accepted: 01/10/2022] [Indexed: 10/19/2022]
Affiliation(s)
- C Mabille
- Department of Infectious Diseases, University Hospital of Amiens-Picardie, Amiens, France.
| | - Y El Samad
- Department of Infectious Diseases, University Hospital of Amiens-Picardie, Amiens, France
| | - C Joseph
- Department of Infectious Diseases, University Hospital of Amiens-Picardie, Amiens, France
| | - B Brunschweiler
- Department of Orthopedic surgery, University Hospital of Amiens-Picardie, Amiens, France
| | - V Goeb
- Department of Rheumatology, University Hospital of Amiens-Picardie, Amiens, France
| | - F Grados
- Department of Rheumatology, University Hospital of Amiens-Picardie, Amiens, France
| | - J P Lanoix
- Department of Infectious Diseases, University Hospital of Amiens-Picardie, Amiens, France
| |
Collapse
|
14
|
Moyet J, Helle F, Bourdenet G, Joseph C, Gubler B, Deschasse G, Defouilloy I, Slovenski T, François C, Liabeuf S, Schmit JL, Lanoix JP, Castelain S, Bloch F, Brochot E. Kinetics of SARS-CoV-2-Neutralising Antibodies of Residents of Long-Term Care Facilities. J Nutr Health Aging 2022; 26:57-63. [PMID: 35067704 PMCID: PMC8683825 DOI: 10.1007/s12603-021-1713-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2021] [Accepted: 11/15/2021] [Indexed: 12/02/2022]
Abstract
INTRODUCTION Elderly residents of nursing homes (NHs) and long-term care units (LTCUs) have been shown to have a high risk of mortality and morbidity in cases of SARS-CoV-2 infection. The objective of this study was to examine the kinetics of neutralizing antibodies (NAbs) directed against the SARS-CoV-2 virus in residents of the NH and LTCU units of our University Hospital who were identified with positive serology after the first epidemic outbreak. MATERIALS AND METHODS The participants included were sampled every three months for qualitative serological testing, as well as quantitative testing by neutralization tests using retroviral particles containing the S glycoprotein of SARS-CoV-2. Vaccination using the Comirnaty (Pfizer BNT162b2) vaccine begun before the last serological follow-up. RESULTS The median NAb titer in June 2020 was 80 [40; 60] versus 40 [40; 160] three months later, showing a statistically significant decline (p < 0.007), but remained stable between the three- and six-month timepoints (p = 0.867). By nine months after vaccination, we observed a significant difference between vaccinated residents known to have positive serology before vaccination (SERO+, Vacc+) and those vaccinated without having previously shown COVID-19 seroconversion (SERO-, Vacc+), the latter group showing similar titers to the SERO+, Vacc- participants (p=0.166). The median antibody titer in SERO+, Vacc+ patients increased 15-fold following vaccination. DISCUSSION Humoral immunity against SARS-CoV-2 appears to be persistent in elderly institutionalized patients, with a good post-vaccination response by residents who had already shown seroconversion but a notably diminished response by those who were seronegative before vaccination. To evaluate immunity in its entirety and elaborate a sound vaccination strategy, the cellular immune response via T cells specific to SARS-CoV-2 merits analysis, as this response is susceptible to being affected by immunosenescence.
Collapse
Affiliation(s)
- J Moyet
- Pr Frédéric Bloch, Department of Gerontology, University Hospital Amiens-Picardie - Hôpital Nord, Place Victor Pauchet - 80054 Amiens Cedex 1, France, Phone / Fax: +333.22.45.57.20 / +333. 22.45.53.30, E-mail: , ORCID identifier : 0000-0002-6046-7097
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Antcliff A, Fox A, Joseph C, Piromalli L, Saunders N, Wells F. Netball injuries in Australia: A review of insurance data from 2011 – 2019. J Sci Med Sport 2021. [DOI: 10.1016/j.jsams.2021.09.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
16
|
Tonnelier M, Bouras A, Joseph C, Samad YE, Brunschweiler B, Schmit JL, Mabille C, Lanoix JP. Impact of rifampicin dose in bone and joint prosthetic device infections due to Staphylococcus spp: a retrospective single-center study in France. BMC Infect Dis 2021; 21:174. [PMID: 33579208 PMCID: PMC7881571 DOI: 10.1186/s12879-021-05832-2] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2020] [Accepted: 01/22/2021] [Indexed: 12/19/2022] Open
Abstract
BACKGROUND Prosthetic joint infections (PJI) are a major cause of morbidity and mortality burden worldwide. While surgical management is well defined, rifampicin (RIF) dose remains controversial. The aim of our study was to determine whether Rifampicin dose impact infection outcomes in PJI due to Staphylococcus spp. METHODS single-center retrospective study including 411 patients with PJI due to Rifampicin-sensitive Staphylococcus spp. Rifampicine dose was categorized as follow: < 10 mg/kg/day, 10-20 mg/kg/day or > 20 mg/kg/day. The primary endpoint was patient recovery, defined as being free of infection during 12 months after the end of the initial antibiotic course. RESULTS 321 (78%) received RIF for the full antibiotic course. RIF dose didn't affect patients recovery rate with 67, 76 and 69% in the < 10, 10-20 and > 20 mg/kg/day groups, respectively (p = 0.083). In univariate analysis, recovery rate was significantly associated with gender (p = 0.012) but not to RIF dose, or Staphylococcus phenotype (aureus or coagulase-negative). In multivariate analysis, age (p = 0.01) and treatment duration (p < 0.01) were significantly associated with recovery rate. CONCLUSION These data suggest that lower doses of RIF are as efficient and safe as the recommended high-dose French regimen in the treatment of PJI.
Collapse
Affiliation(s)
- M Tonnelier
- Infectious diseases department, CHU Amiens Nord, 1 place Victor Pauchet, 80000, Amiens, France.
- Centre hospitalier Compiègne-Noyon - service MIPI, 8 avenue Henri Adnot, 60200, Compiègne, France.
| | - A Bouras
- Infectious diseases department, CHU Amiens Nord, 1 place Victor Pauchet, 80000, Amiens, France
| | - C Joseph
- Infectious diseases department, CHU Amiens Nord, 1 place Victor Pauchet, 80000, Amiens, France
- UR 4294 AGIR, Université Picardie Jules Verne, 1-3 rue des Louvels, 80000, Amiens, France
| | - Y El Samad
- Infectious diseases department, CHU Amiens Nord, 1 place Victor Pauchet, 80000, Amiens, France
| | - B Brunschweiler
- Orthopedic department, CHU Amiens Sud, 1 rue du Professeur Christian Cabrol, 80054, Amiens, France
| | - J-L Schmit
- Infectious diseases department, CHU Amiens Nord, 1 place Victor Pauchet, 80000, Amiens, France
- UR 4294 AGIR, Université Picardie Jules Verne, 1-3 rue des Louvels, 80000, Amiens, France
| | - C Mabille
- Pharmacy department, CHU Amiens Sud, 1 rue du Professeur Christian Cabrol, 80054, Amiens, France
| | - J-P Lanoix
- Infectious diseases department, CHU Amiens Nord, 1 place Victor Pauchet, 80000, Amiens, France
- UR 4294 AGIR, Université Picardie Jules Verne, 1-3 rue des Louvels, 80000, Amiens, France
| |
Collapse
|
17
|
Chan Sui Ko A, El Samad Y, Joseph C, Guiheneuf R, Schmit JL, Lanoix JP. Atypical pneumonia clusters. Infect Dis Now 2020; 51:101-104. [PMID: 33160009 DOI: 10.1016/j.medmal.2020.10.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2020] [Revised: 04/17/2020] [Accepted: 10/27/2020] [Indexed: 11/29/2022]
Affiliation(s)
- A Chan Sui Ko
- Department of infectious and tropical diseases, CHU de Amiens, 1, rue du Professeur-Christian-Cabrol, 80000 Amiens, France.
| | - Y El Samad
- Department of infectious and tropical diseases, CHU de Amiens, 1, rue du Professeur-Christian-Cabrol, 80000 Amiens, France
| | - C Joseph
- Department of infectious and tropical diseases, CHU de Amiens, 1, rue du Professeur-Christian-Cabrol, 80000 Amiens, France; AGIR: EA4294 Amiens, Amiens, France
| | - R Guiheneuf
- AGIR: EA4294 Amiens, Amiens, France; Bacteriology laboratory, CHU de Amiens, Amiens, France
| | - J L Schmit
- Department of infectious and tropical diseases, CHU de Amiens, 1, rue du Professeur-Christian-Cabrol, 80000 Amiens, France; AGIR: EA4294 Amiens, Amiens, France
| | - J P Lanoix
- Department of infectious and tropical diseases, CHU de Amiens, 1, rue du Professeur-Christian-Cabrol, 80000 Amiens, France; AGIR: EA4294 Amiens, Amiens, France
| |
Collapse
|
18
|
Alsukhon J, Chatfield A, Zoratti E, Kim H, Sitarik A, Havstad S, Johnson C, Joseph C, Wegienka G. P050 PRENATAL PET EXPOSURE AND TOTAL SERUM IGE TRAJECTORY AT 10 YEARS OF AGE. Ann Allergy Asthma Immunol 2020. [DOI: 10.1016/j.anai.2020.08.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
19
|
Nadau E, Joseph C, Haraux E, Deroussen F, Gouron R, Klein C. Clinical features and outcomes in children with bone and joint infections of the ankle or foot. Arch Pediatr 2020; 27:464-468. [PMID: 33011034 DOI: 10.1016/j.arcped.2020.08.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2019] [Revised: 05/11/2020] [Accepted: 08/11/2020] [Indexed: 11/18/2022]
Abstract
BACKGROUND The foot and ankle are uncommon sites of bone and joint infections (BJIs) in children. The objectives of the present study were to determine the clinical and bacteriologic features of BJIs and to assess any associated complications and orthopedic sequelae. METHODS We performed a retrospective, single-center study of children treated for foot or ankle BJIs between 2008 and 2018 in a French university medical center. A total of 23 children were included. The median age at diagnosis was 9.1 years. Osteomyelitis was noted in 14 cases; it involved the calcaneus in seven cases, the distal fibula in four cases, the first metatarsal in two cases, and the distal tibia in one case. Arthritis affected the ankle in six cases and the cuneiform-cuboidal joint in one case. In two cases, osteoarthritis of the ankle was associated with distal osteomyelitis of the tibia. Clinical, radiological, and bacteriological parameters, surgical procedures, complications, and sequelae were recorded and analyzed. RESULTS The median (range) time to diagnosis was 3.18 days (0-10), and trauma was reported in four cases. Fever was present on admission in 18 cases, and the serum C-reactive protein level was elevated in 22 cases. Standard X-rays showed osteolysis in one case and bone sequestration in another. Staphylococcusaureus was identified in 10 cases. Surgery was performed in 17 cases. A subperiosteal abscess that required surgical drainage complicated 10 cases of osteomyelitis. No recurrence was observed. At the last follow-up, the median (range) age was 11.9 years (1.5-19). Sequelae (spontaneous tibia-talus fusion, first metatarsal epiphysis fusion, and varus deformity of the hindfoot) were observed in three cases, all of which were initially complicated by an abscess. CONCLUSION Physicians should be aware that pediatric BJIs of the lower limb may involve the foot and ankle. S. aureus is frequently involved. In cases of osteomyelitis, complications are closely associated with subperiosteal abscesses justifying an early diagnosis. These BJIs must be treated rapidly, and the risk of sequelae justifies long-term follow-up.
Collapse
Affiliation(s)
- E Nadau
- Department of pediatric orthopedics, Jules-Verne university of Picardie and Amiens Picardie university medical center, 80054 Amiens cedex 1, France
| | - C Joseph
- Department of infectious disease, Jules-Verne university of Picardie and Amiens Picardie university medical center, 80054 Amiens cedex 1, France; AGIR group, microbiology research unit, EA4294, Jules-Verne university of Picardie, 80054 Amiens cedex 1, France
| | - E Haraux
- Department of pediatric orthopedics, Jules-Verne university of Picardie and Amiens Picardie university medical center, 80054 Amiens cedex 1, France
| | - F Deroussen
- Department of pediatric orthopedics, Jules-Verne university of Picardie and Amiens Picardie university medical center, 80054 Amiens cedex 1, France
| | - R Gouron
- Department of pediatric orthopedics, Jules-Verne university of Picardie and Amiens Picardie university medical center, 80054 Amiens cedex 1, France
| | - C Klein
- Department of pediatric orthopedics, Jules-Verne university of Picardie and Amiens Picardie university medical center, 80054 Amiens cedex 1, France.
| |
Collapse
|
20
|
Madasa V, Boggenpoel B, Phillips J, Joseph C. Mortality and secondary complications four years after traumatic spinal cord injury in Cape Town, South Africa. Spinal Cord Ser Cases 2020; 6:84. [PMID: 32887870 DOI: 10.1038/s41394-020-00334-w] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2020] [Revised: 08/20/2020] [Accepted: 08/24/2020] [Indexed: 11/09/2022] Open
Abstract
STUDY DESIGN A prospective, regional, population-based study. OBJECTIVES (1) Determine the mortality rate and factors associated with it 4 years after a TSCI and (2) The point prevalence of secondary medical complications of survivors at 4 years. SETTING Communities of the Cape metropolitan area, South Africa. METHODS All persons (n = 145) sustaining a TSCI from 15 September 2013 to 14 September 2014 were eligible for follow-up at 4 years. Participants were contacted after 4 years. The next of kin, via verbal autopsy, was used to establish cause of death. Those who were alive at 4 years were asked to indicate any secondary medical complications. Logistic regression techniques were used to identify independently associated risk indicators for death and development of secondary complications, respectively. RESULTS Of the initial 145 persons, 87 were included and accounted for. Of these, 21 (24%) had died, 55 (63%) were alive and completed the survey, and 11 (13%) were classified as alive but did not submit the survey. The main cause of death reported was septicaemia (n = 7; 33%), followed by unknown natural causes (n = 7; 33%), then pressure injuries (n = 5; 24%). Out of the 55 persons alive, 89% had at least one medical complication at the time of enquiry, while more than 50% experienced 6 or more complications. The most common complications were pain (80%), muscle spasms (76%), sleeping problems (56%), and bladder dysfunction (44%). CONCLUSIONS Almost one-quarter of persons with TSCI have died 4 years after injury. Also, secondary complications were found to be highly prevalent at 4 years. This information could be used to develop secondary complications prevention programmes to reduce premature deaths. SPONSORSHIP This study was funded by the Medical Research Council of South Africa within the Research Capacity Development Initiative.
Collapse
Affiliation(s)
- V Madasa
- Physiotherapy Department, Faculty of Community and Health Sciences, University of the Western Cape, Cape Town, South Africa
| | - B Boggenpoel
- Physiotherapy Department, Faculty of Community and Health Sciences, University of the Western Cape, Cape Town, South Africa
| | - J Phillips
- Physiotherapy Department, Faculty of Community and Health Sciences, University of the Western Cape, Cape Town, South Africa
| | - C Joseph
- Division of Physiotherapy, Department of Health and Rehabilitation Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
| |
Collapse
|
21
|
|
22
|
Bhave KG, Jawahar KTP, Kumarasamy P, Sivakumar T, Joseph C, Shirsath T, Deshmukh P, Venkataramanan R. Genetic and non-genetic factors affecting semen production and quality characteristics of Gir cattle breed under semi-arid climate. Vet World 2020; 13:1714-1718. [PMID: 33061249 PMCID: PMC7522933 DOI: 10.14202/vetworld.2020.1714-1718] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2020] [Accepted: 07/07/2020] [Indexed: 11/16/2022] Open
Abstract
Aim This study aims to evaluate genetic and non-genetic factors influencing semen production potential of Gir bulls. Materials and Methods Data on semen quantity (n=6911) and quality (n=466) available from January 2011 to December 2018 at BAIF's frozen semen station, Jind, Haryana, India, were utilized for the study. Factors, namely, season of collection, age at collection, and bull (random effect) were studied for their effect on quantitative and qualitative semen traits. Least square means for the traits were obtained using a general linear model. The effect of age within bull for repeatable traits was analyzed using a longitudinal model with age as the control variable. Multivariate analysis using mixed repeatability model equation was utilized to estimate bull effect correlation (genetic + permanent environmental correlation), phenotypic correlations, and repeatability. Results The overall least square means of ejaculate volume, sperm concentration, total sperms, initial and post-thaw motility, hypo-osmotic swelling test, and acrosome integrity of frozen semen were 6.62±0.03 ml, 1.22±0.01 109/ml, 8.09±0.05 109/ejaculate, 75.78±0.001%, 55.92±0.0001%, 55.13±0.005%, and 71.08±0.001%, respectively. The season of the collection showed a significant effect on volume, concentration, total sperm, and initial motility. The performance of bulls was superior in summer season, followed by winter and monsoon. Increase in semen attributes during summer season was due to the effect of lower temperature on sensitive stages of spermatogenesis. Age at collection had a significant effect on all semen traits. Volume and total sperm count showed increasing trend while concentration showed a decreasing trend with an increase in age. Motility and quality traits did not show any particular pattern. Individual bulls showed differences in all the semen performance traits with age. The repeatability of the traits ranged from 0.04 (HOST) to 0.58 (acrosome integrity). Bull effect correlation ranged from -0.73 (initial motility and acrosome integrity) to 0.93 (HOST and acrosome integrity). Conclusion Individual bulls showed variation in traits measured over age. The result of the study could be utilized in suggesting suitable management plans to achieve the desired profit by improving semen quality in Gir bulls.
Collapse
Affiliation(s)
- K G Bhave
- Department of Animal Genetics and Breeding, Madras Veterinary College, Tamil Nadu Veterinary and Animal Sciences University, Chennai, Tamil Nadu, India
| | - K Thilak Pon Jawahar
- Department of Animal Genetics and Breeding, Madras Veterinary College, Tamil Nadu Veterinary and Animal Sciences University, Chennai, Tamil Nadu, India
| | - P Kumarasamy
- Controller of Examinations, Madhavaram Milk Colony, Tamil Nadu Veterinary and Animal Sciences University, Chennai, Tamil Nadu, India
| | - T Sivakumar
- Dean, Veterinary College and Research Institute, Orathanadu, Thanjavur, Tamil Nadu, India
| | - C Joseph
- Director of Research, Madhavaram Milk Colony, Tamil Nadu Veterinary and Animal Sciences University, Chennai, Tamil Nadu, India
| | - T Shirsath
- Frozen semen laboratory, BAIF, Development Research Foundation, Dr. Manibhai Desai Nagar, Uruli Kanchan, Pune, Maharashtra, India
| | - P Deshmukh
- Frozen semen laboratory, BAIF, Development Research Foundation, Dr. Manibhai Desai Nagar, Uruli Kanchan, Pune, Maharashtra, India
| | - R Venkataramanan
- Livestock Farm Complex, Madhavaram Milk Colony, Tamil Nadu Veterinary and Animal Sciences University, Chennai, Tamil Nadu, India
| |
Collapse
|
23
|
Joseph C, Bilgrami SM, Ottewell L, Gray L, Mitchell W, Wood F, Massarotti M, Bukhari M. THU0205 RESPONSE TO SMALL MOLECULES IS MOSTLY DRIVEN BY PATIENT GLOBAL ASSESSMENT OF DISEASE: A REAL WORLD OBSERVATION. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.3118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Two Small molecules (Tofacitinib and Baricitinib) have been licensed in the UK for the use in rheumatoid arthritis. Their licensing came from several studies that showed good efficacy with baricitinib (1) study showing superior efficacy to adalimumab and tofacitinib showing non inferiority to TNF drugs (2). The response has also been shown in patient reported outcomes (find reference). Response when measure using the DAS score has two relatively subjective components (tender joints and patient global assessment) and two relatively objective components (Swollen joints and inflammatory markers)Objectives:To determine in a real world setting if the response to small molecules is mostly due to a drop in subjective or objective components of the DAS scoreMethods:A retrospective chart review was done on all new starters on small molecules in a district hospital in the North of England. Data were collected at baseline, three months and six months from October 2018 to date. Drop in the components of the DAS28 score was calculated and overall drop in DAS28 was modelled as the explanatory variable using linear regression modelling. This was the done Adjusting for age gender and duration of disease. Sensitivity of the model was examined using a logistic model of EULAR moderate/good response and using adjusted R squared estimates for linear model of improvement of the DAS28 score.Results:76 patients were included in the analysis from 85 starters on small molecules.61 (71.8 %) were on baricitinib and the baseline median DAS28 score was .5.97 (IQR 5.35,6.55)The median drop at three months in the DAS28 score was 2.42 (IQR 1.33,3.31). and at six months was 2.77 (IQR 2.01,3.83). There was numerical relative increased efficacy of baricitinib but this was not statistically significant (DAS drop at three months 2.54 IQR 1.73,3.09 vs 2.12 IQR 1.51,3.5). The relative contribution of the individual components of the DAS score to the drop ae in DAS are shown in table 1 below. Sensitivity analysis looking at predictors of a DAS drop of >0.6 confirmed this finding.Table 1.Results of the adjusted linear regression models.Component of DAS dropping at three monthsAdjusted R squared at 3 monthsAdjusted R squared at six monthsSwollen Joints0.120.05Tender Joints0.280.18Patient global assessment0.310.48Erythrocyte sedimentation rate0.040.17Conclusion:In this real world observational study, there was a good response to both small molecules with numerical better response to baricitinib. Tender joint count and patient global response accounted for more of the drop in DAS28 than swollen joints and inflammatory markers. At six months the biggest contributor to response was patient global assessment. This shows that JAK inhibitors might mediate their response initially mostly through pain modulation then by inflammation as exposure to drug continues.References:[1]N Engl J Med. 2017 Feb 16;376(7):652-662[2]N Engl J Med. 2014 Jun 19;370(25):2377-86Disclosure of Interests: :Clerin Joseph: None declared, Syed Mujtaba Bilgrami Speakers bureau: Pfizer, Lesley Ottewell: None declared, Leanne Gray: None declared, William Mitchell: None declared, Fiona Wood: None declared, Marco Massarotti: None declared, Marwan Bukhari Speakers bureau: Bristol-Myers Squib, UCB celltech, Roche/Chugai, Pfizer, Abbvie, Merck, Mennarini, Sanofi-aventis, Eli-Lilly, Janssen, Amgen and Novartis.
Collapse
|
24
|
Mabille C, El Samad Y, Joseph C, Brunschweiler B, Goeb V, Grados F, Lanoix JP. Medical versus surgical treatment in native hip and knee septic arthritis. Infect Dis Now 2020; 51:164-169. [PMID: 32387296 DOI: 10.1016/j.medmal.2020.04.019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2019] [Revised: 01/07/2020] [Accepted: 04/28/2020] [Indexed: 10/24/2022]
Abstract
OBJECTIVE Antibiotic treatment and arthroscopic or open drainage is the gold standard for septic arthritis. Full recovery takes time after surgery and hospital stay is longer than for arthrocentesis at the bedside. We aimed to evaluate the effectiveness of arthrocentesis (medical approach) versus a surgical approach. METHOD We retrospectively included 97 cases of native joint arthritis (hip and knee) between 2010 and 2017. The primary outcome was treatment failure of medical and surgical approaches (defined as surgical intervention within 7 days following diagnosis). Risk factors of failure were identified by univariable and multivariable logistic regression. RESULTS We included 72 cases of knee arthritis, of which 43 and 29 were treated medically and surgically, respectively; 25 cases of hip arthritis, of which 8 and 17 were treated medically and surgically, respectively. Failure was observed in 39.2% of cases in the medical group and in 30.4% in the surgical group (P=0.2) (37.5% vs. 52.9% and 39.5% vs. 17.2% for hip and knee, respectively). The univariate analysis identified age and male sex as risk factors for failure (P=0.048 and P=0.02, respectively), but only age was independently associated with failure (P=0.04). Hospital length of stay was 12 days shorter in the medical group (21 vs. 33 days, P=0.02), sequelae were less frequent and less important in the medical group (31.7% vs. 60%). CONCLUSION The medical treatment seems to be as effective as the surgical treatment for native joint septic arthritis with a shorter hospital stay and better functional outcome. Further prospective studies are warranted.
Collapse
Affiliation(s)
- C Mabille
- Department of Infectious Diseases, University Hospital of Amiens-Picardie, Amiens, France.
| | - Y El Samad
- Department of Infectious Diseases, University Hospital of Amiens-Picardie, Amiens, France
| | - C Joseph
- Department of Infectious Diseases, University Hospital of Amiens-Picardie, Amiens, France
| | - B Brunschweiler
- Department of Orthopedic surgery, University Hospital of Amiens-Picardie, Amiens, France
| | - V Goeb
- Department of Rheumatology, University Hospital of Amiens-Picardie, Amiens, France
| | - F Grados
- Department of Rheumatology, University Hospital of Amiens-Picardie, Amiens, France
| | - J P Lanoix
- Department of Infectious Diseases, University Hospital of Amiens-Picardie, Amiens, France
| |
Collapse
|
25
|
Joseph C, Petit C, Schmit JL, Drancourt M, Pluquet E, Lanoix JP. Community-acquired granulomatous mastitis superinfected with Mycobacterium bolletii. Med Mal Infect 2019; 50:291-292. [PMID: 31806269 DOI: 10.1016/j.medmal.2019.11.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2019] [Accepted: 11/04/2019] [Indexed: 11/25/2022]
Affiliation(s)
- C Joseph
- Infectious Diseases Department, University Hospital, Amiens, France; AGIR: Microbiology Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France.
| | - C Petit
- Infectious Diseases Department, University Hospital, Amiens, France
| | - J L Schmit
- Infectious Diseases Department, University Hospital, Amiens, France; AGIR: Microbiology Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France
| | - M Drancourt
- Microbiology Laboratory, Hygiene, Hospital Epidemiology, La Timone Hospital, University Hospital, Marseille, France
| | - E Pluquet
- Bacteriology Laboratory, University Hospital, Amiens, France; AGIR: Microbiology Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France
| | - J P Lanoix
- Infectious Diseases Department, University Hospital, Amiens, France; AGIR: Microbiology Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France
| |
Collapse
|
26
|
Boelkins B, Chatfield A, Sitarik A, Kim H, Joseph C, Wegienka G, Ownby D, Cole Johnson C, Zoratti E. A101 ANALYSIS OF ALLERGEN SPECIFIC IGE CUT POINTS TO CAT, DOG AND GRASS IN CHILDREN. Ann Allergy Asthma Immunol 2019. [DOI: 10.1016/j.anai.2019.08.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
27
|
Joseph C, Hawksworth D, Campbell J, Burnett A. 236 Long-standing Diabetes and Poor Glycemic Control Result in Worse Peyronie's Curvature. J Sex Med 2019. [DOI: 10.1016/j.jsxm.2019.01.243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
28
|
Joseph C, Robineau O, Titecat M, Putman S, Blondiaux N, Loiez C, Valette M, Schmit JL, Beltrand E, Dézeque H, Nguyen S, Migaud H, Senneville E. Daptomycin versus Vancomycin as Post-Operative Empirical Antibiotic Treatment for Prosthetic Joint Infections: A Case-Control Study. J Bone Jt Infect 2019; 4:72-75. [PMID: 31011511 PMCID: PMC6470651 DOI: 10.7150/jbji.22118] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/21/2017] [Accepted: 06/16/2018] [Indexed: 12/31/2022] Open
Abstract
Purpose: To compare safety and efficacy of Vancomycin (Van) versus Daptomycin (Dap) as post-operative empirical antibiotic treatment (PEAT) in patients with periprosthetic joint infections (PJIs). Methods: Medical charts of patients treated empirically with Van or Dap in the post-operative period of total hip/knee prosthesis septic revision until the results of intra-operative culture were reviewed. Cefotaxime, cefepime or aztreonam were used in combination with Dap or Van. Results: Twenty Dap patients were matched with 20 other Van patients according to the age and type of prosthesis. The ASA score and the distribution of the pathogens was similar in the two groups especially regarding the number of methicillin-resistant staphylococci. The mean duration of the PEAT was 6.07 ± 0.85 days. A total of 17 episodes of adverse events (AE) in 10 patients (25%) were recorded during the PEAT which led to discontinue the treatment in 5 patients, all of them treated with Van (P=0.02). At the end of a mean post-treatment follow-up of 618 +/- 219 days, 36 patients remained in remission of infection; 2 patients failed in each group. Conclusions: Our observations suggest that PEAT with Van for septic revision of PJIs is associated with a higher discontinuation rate due to AE but with a similar outcome than it is with Dap.
Collapse
Affiliation(s)
- C Joseph
- Infectious Diseases Department, University Hospital of Amiens, France
| | - O Robineau
- Infectious Diseases Department, Gustave Dron Hospital of Tourcoing, France.,Faculty of Medicine of Lille, Lille University 2
| | - M Titecat
- Faculty of Medicine of Lille, Lille University 2.,Laboratory of Microbiology, University Hospital of Lille, France
| | - S Putman
- Orthopaedic Surgery Unit, University Hospital of Lille, France
| | - N Blondiaux
- Laboratory of Microbiology, Gustave Dron Hospital of Tourcoing, France
| | - C Loiez
- Laboratory of Microbiology, University Hospital of Lille, France
| | - M Valette
- Infectious Diseases Department, Gustave Dron Hospital of Tourcoing, France
| | - J L Schmit
- Infectious Diseases Department, University Hospital of Amiens, France
| | - E Beltrand
- Orthopedic Surgery Unit, Gustave Dron Hospital, France
| | - H Dézeque
- Orthopaedic Surgery Unit, University Hospital of Lille, France
| | | | - H Migaud
- Faculty of Medicine of Lille, Lille University 2.,Orthopaedic Surgery Unit, University Hospital of Lille, France
| | - E Senneville
- Infectious Diseases Department, Gustave Dron Hospital of Tourcoing, France.,Faculty of Medicine of Lille, Lille University 2.,Orthopaedic Surgery Unit, University Hospital of Lille, France
| |
Collapse
|
29
|
Abou-Jaoude E, Sitarik A, Havstad S, Ownby D, Jones K, Kim H, Joseph C, Zoratti E. ASSOCIATION BETWEEN PACIFIER CLEANING METHODS AND CHILD TOTAL IGE. Ann Allergy Asthma Immunol 2018. [DOI: 10.1016/j.anai.2018.09.148] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
30
|
Joseph C, Rönnpagel V, Ullrich A, Runge D, Grube M. Drug transporter expression in non-parenchymal liver cells in comparison to hepatocytes. Toxicol Lett 2018. [DOI: 10.1016/j.toxlet.2018.06.643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
31
|
Drzal N, Alaimo K, Henne B, Pringle L, Joseph C, Donovan M. Michigan Team Nutrition and Michigan State University Extension Healthy School Meal Training Model. J Acad Nutr Diet 2018. [DOI: 10.1016/j.jand.2018.06.023] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
32
|
Drzal N, Alaimo K, Henne B, Pringle L, Joseph C, Donovan M. Evaluation of a Michigan Team Nutrition and Michigan State University Extension Smarter Lunchroom Initiative. J Acad Nutr Diet 2018. [DOI: 10.1016/j.jand.2018.06.167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
33
|
Moritz E, Witschel V, Luehr J, Joseph C, Boehm A, Rauch BH. P1845The pro-inflammatory signaling lipid sphingosine-1-phosphate regulates gene and protein expression of both tissue factor and plasminogen activator inhibitor-1 in differentiated fat cells. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p1845] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- E Moritz
- University Medicine of Greifswald, Institute of Pharmacology, Greifswald, Germany
| | - V Witschel
- University Medicine of Greifswald, Institute of Pharmacology, Greifswald, Germany
| | - J Luehr
- University Medicine of Greifswald, Institute of Pharmacology, Greifswald, Germany
| | - C Joseph
- University Medicine of Greifswald, Institute of Pharmacology, Greifswald, Germany
| | - A Boehm
- University Medicine of Greifswald, Institute of Pharmacology, Greifswald, Germany
| | - B H Rauch
- University Medicine of Greifswald, Institute of Pharmacology, Greifswald, Germany
| |
Collapse
|
34
|
Cuamatzi-Castelan AS, Cheng P, Fellman-Couture C, Tallent G, Tran KM, Espie CA, Joseph C, Roehrs T, Drake CL. 0375 Long-term Efficacy of the Sleep to Prevent Evolving Affective Disorders (SPREAD) Trial as an Internet-based Treatment for Insomnia. Sleep 2018. [DOI: 10.1093/sleep/zsy061.374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
| | - P Cheng
- Henry Ford Health Systems, Novi, MI
| | | | | | - K M Tran
- Henry Ford Health Systems, Novi, MI
| | | | - C Joseph
- Henry Ford Health Systems, Novi, MI
| | - T Roehrs
- Henry Ford Health Systems, Detroit, MI
| | | |
Collapse
|
35
|
Kasimanickam RK, Hall JB, Estill CT, Kastelic JP, Joseph C, Abdel Aziz RL, Nak D. Flunixin meglumine improves pregnancy rate in embryo recipient beef cows with an excitable temperament. Theriogenology 2017; 107:70-77. [PMID: 29132037 DOI: 10.1016/j.theriogenology.2017.10.043] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2017] [Revised: 10/25/2017] [Accepted: 10/30/2017] [Indexed: 11/18/2022]
Abstract
Objectives were to determine effects of: 1) handling temperament and administration of flunixin meglumine, an inhibitor of prostaglandin F2a (PGF2a) synthesis, given at the time of embryo transfer, on pregnancy rates in beef cattle embryo transfer recipients; 2) handling temperament and flunixin meglumine on peripheral concentrations of progesterone, cortisol, substance-P, prostaglandin F metabolites (PGFM, (13,14-dihydro-15-keto-PGF2a) and isoprostane 8-epi PGF2a; and 3) flunixin meglumine treatment on proportion of non-pregnant recipient cows returning to estrus within an expected interval. Angus cross beef cows (n = 710) at 7 locations were assigned a body condition score (BCS: 1, emaciated; 9, obese) and a temperament score [0, calm, slow chute exit; walk (n = 352), 1, excited, fast chute exit; jump, trot or run (n = 358)] and were synchronized with Select-Synch with a controlled internal drug release (CIDR) protocol. Estrus detection aids were applied at CIDR removal and cows were observed thrice daily for estrus until 72 h. Recipient cows that expressed estrus and had a corpus luteum received a frozen-thawed embryo on Day 7 after estrus. At the time of transfer, recipient cows were randomly allocated to receive 10 mL of flunixin meglumine im, immediately after transfer (n = 365) or served as an untreated control (n = 345). In a subset of cows (n = 80), ovarian ultrasonography was performed on the day of embryo transfer to determine corpus luteum volume and blood samples were collected twice, at the time of embryo transfer and 7 d later. All cows received estrus detection aids again on Day 14 (7 d after embryo transfer) and were observed for estrus twice daily until Day 24. Accounting for treatment (P > 0.1), embryo transfer difficulty score (P < 0.1), temperament by treatment interaction (P < 0.05), recipient cows with calm temperament had a higher pregnancy rate compared to those with an excited temperament [59.4 (209/352) vs 51.7% (185/358)]. The pregnancy rate for excitable cows without flunixin meglumine was lower (46.3% 81/175) compared to excitable cows that did received flunixin meglumine [56.8% (104/183)], and calm cows that did [59.3% (108/182)] or did not [59.4% (104/170)] receive flunixin meglumine. Proportions of non-pregnant recipient cows returning to estrus on Days 18-24 were not different between flunixin meglumine and control groups, 87.6% (134/153) and 84.0% (137/163), respectively (P > 0.1). At the time of embryo transfer and 7 d later, there were moderate to strong correlations among circulating concentrations of progesterone, cortisol, substance-P, PGFM and isoprostane 8-epi PGF2a. Among excitable cows, progesterone concentrations were lower and cortisol, substance-P, PGFM and isoprostane 8-epi PGF2a concentrations were greater for cows in the control group compared to cows that received flunixin meglumine. In conclusion, administration of flunixin meglumine improved pregnancy rates in excitable recipient cows following embryo transfer without affecting the proportion of non-pregnant cows returning to estrus.
Collapse
Affiliation(s)
- R K Kasimanickam
- Department of Veterinary Clinical Sciences, Washington State University, Pullman, WA, USA.
| | - J B Hall
- Nancy M. Cummings Research, Extension and Education Center, University of Idaho, Carmen, ID, USA
| | - C T Estill
- Department of Clinical Sciences, Oregon State University, Corvallis, OR, USA
| | - J P Kastelic
- Department of Production Animal Health, University of Calgary, Calgary, AB, Canada
| | - C Joseph
- Department of Clinics, Tamil Nadu Veterinary and Animal Sciences University, Vepery, Chennai, India
| | - R L Abdel Aziz
- Department of Theriogenology, Beni-Suef University, Beni-Suef, Egypt
| | - D Nak
- Department of Obstetrics and Gynecology, Uludag University Veterinary Faculty, Bursa, Turkey
| |
Collapse
|
36
|
Perera N, Kemp J, Joseph C, Kountouris A, Finch C. Hospital treated cricket injuries in community level female players: An analysis of hospital-presentation data from Victoria and Queensland, 2002–03 to 2013–14, inclusive. J Sci Med Sport 2017. [DOI: 10.1016/j.jsams.2017.09.273] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
37
|
Affiliation(s)
- A. Rhoda
- Department of Physiotherapy, Faculty of Community and Health Sciences, University of the Western Cape, Cape Town, South Africa
| | - J. Smith
- Department of Physiotherapy, Faculty of Community and Health Sciences, University of the Western Cape, Cape Town, South Africa
| | - C. Joseph
- Department of Physiotherapy, Faculty of Community and Health Sciences, University of the Western Cape, Cape Town, South Africa
- Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institute, Stockholm, Sweden
| |
Collapse
|
38
|
Abbasi M, Gupta V, Dheer Y, Joseph C, Vanderwall R, Graham S. Effects of Caveolin-1 ablation in the inner retina under healthy and experimental glaucoma conditions. Acta Ophthalmol 2017. [DOI: 10.1111/j.1755-3768.2017.04122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- M. Abbasi
- Macquarie University; Clinical Medicine; Sydney Australia
| | - V. Gupta
- Macquarie University; Clinical Medicine; Sydney Australia
| | - Y. Dheer
- Macquarie University; Clinical Medicine; Sydney Australia
| | - C. Joseph
- Macquarie University; Clinical Medicine; Sydney Australia
| | - R. Vanderwall
- Macquarie University; Clinical Medicine; Sydney Australia
| | - S.L. Graham
- Macquarie University; Clinical Medicine; Sydney Australia
| |
Collapse
|
39
|
Siauve J, Lanoix J, Boursier A, Joseph C, Sejourne A, Vaidie A, Salle V, Hanat S, Denamps J, El Samad Y. Juste prescription d’antibiotiques, où en sommes-nous dans notre CHU ? Med Mal Infect 2017. [DOI: 10.1016/j.medmal.2017.03.113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
40
|
Sidharthan N, Sudevan R, Narayana Pillai V, Mathew S, Raj M, Viswam D, Joseph C, Sudhakar A. Low-dose prophylaxis for children with haemophilia in a resource-limited setting in south India-A clinical audit report. Haemophilia 2017; 23:e382-e384. [DOI: 10.1111/hae.13272] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/17/2017] [Indexed: 11/28/2022]
Affiliation(s)
- N. Sidharthan
- Amrita Institute of Medical Sciences and Research Centre; Cochin India
| | - R. Sudevan
- Amrita Institute of Medical Sciences and Research Centre; Cochin India
| | | | - S. Mathew
- Hemophilia Treatment Centre Aluva; Kochi India
| | - M. Raj
- Amrita Institute of Medical Sciences and Research Centre; Cochin India
| | - D. Viswam
- Hemophilia Treatment Centre Aluva; Kochi India
| | - C. Joseph
- Hemophilia Treatment Centre Aluva; Kochi India
| | - A. Sudhakar
- Amrita Institute of Medical Sciences and Research Centre; Cochin India
| |
Collapse
|
41
|
Drake C, Cheng P, Luik A, Peterson E, Joseph C, Tallent G, Tran K, Ahmedani B, Roehrs T, Roth T. 0353 PRELIMINARY DATA FOR THE SLEEP TO PREVENT EVOLVING AFFECTIVE DISORDERS (SPREAD) TRIAL. Sleep 2017. [DOI: 10.1093/sleepj/zsx050.352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
42
|
Muller-Bolla M, Joseph C, Pisapia M, Tramini P, Velly AM, Tassery H. Performance of a recent light fluorescence device for detection of occlusal carious lesions in children and adolescents. Eur Arch Paediatr Dent 2017; 18:187-195. [DOI: 10.1007/s40368-017-0285-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2016] [Accepted: 03/02/2017] [Indexed: 10/19/2022]
|
43
|
Joseph C, Andersson N, Bjelak S, Giesecke K, Hultling C, Wikmar L, Phillips J, Seiger Ã, Stenimahitis V, Trok K, Ã…kesson E, Wahman K. Incidence, aetiology and injury characteristics of traumatic spinal cord injury in Stockholm, Sweden: A prospective, population-based update. J Rehabil Med 2017; 49:431-436. [DOI: 10.2340/16501977-2224] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
44
|
Perera NP, Kemp J, Joseph C, Kountouris A, Finch C. Injures in Australian female cricketers and their treatment sources: An analysis of self-reported survey data from 2014-15 season. J Sci Med Sport 2017. [DOI: 10.1016/j.jsams.2017.01.180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
45
|
Schamm M, Jugmohan B, Joseph C, Botha JR, Botha JF, Britz R, Loveland J. Kidney transplant outcomes following the introduction of hand-assisted laparoscopic living donor nephrectomy: a comparison of recipient groups. S AFR J SURG 2015; 53:63-66. [PMID: 28240487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
BACKGROUND Laparoscopic donor nephrectomy has become the procedure of choice for living donor kidney transplantation in many centres. We report on our experience with hand-assisted laparoscopic donor nephrectomy (HALDN). We concentrated on graft function and postoperative surgical complications in the recipient population, and compared outcomes to a similar recipient group who had received kidneys procured by open living-donor nephrectomy (OLDN). METHOD Following the receipt of institutional approval, the files of all patients who received a kidney transplant between September 2008 and June 2011 were reviewed. One hundred patients with end-stage renal disease received kidney transplantations from living donors. OLDN was performed in 65 donors, and 35 underwent HALDN. Delayed graft function (DGF) and postoperative complications were recorded. RESULTS Six adverse events were reported, during which five patients presented with DGF. One DGF was reported in the HALDN group, and four in the OLDN group. The morbidity in the HALDN group (1/35, 3%) was a graft rupture secondary to acute rejection which required exploration and transplant nephrectomy. Reoperation was required in five patients in the OLDN group (5/65, 8%). This amounted to overall morbidity of 6%, with no recipient mortalities. CONCLUSION As previously documented, HALDN is safe for the donor, and not inferior to OLDN. In this study, it was associated with neither an increased incidence of DGF, nor a higher complication rate in the transplant recipient, when compared to the cohort that received a kidney harvested using the OLDN technique.
Collapse
Affiliation(s)
- M Schamm
- Transplant Division, Department of General Surgery, University of the Witwatersrand, South Africa
| | - B Jugmohan
- Transplant Division, Department of General Surgery, University of the Witwatersrand, South Africa
| | - C Joseph
- Transplant Division, Department of General Surgery, University of the Witwatersrand, South Africa
| | - J R Botha
- Transplant Division, Department of General Surgery, University of the Witwatersrand, South Africa
| | - J F Botha
- Transplant Division, Department of General Surgery, University of the Witwatersrand, South Africa
| | - R Britz
- Transplant Division, Department of General Surgery, University of the Witwatersrand, South Africa
| | - J Loveland
- Transplant Division, Department of General Surgery, University of the Witwatersrand, South Africa
| |
Collapse
|
46
|
Eggimann P, Joseph C, Thévenin MJ. Fitness of use of Biopatch® and TegadermTM CHG for protecting central venous catheters and arterial lines in critically ill patients. Antimicrob Resist Infect Control 2015. [PMCID: PMC4474738 DOI: 10.1186/2047-2994-4-s1-o26] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
47
|
Joseph C, Wikmar LN. Living with a long-term traumatic spinal cord injury in South Africa: experiences related to readjustment and attained participation (self-perceived). Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.3545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
48
|
Kolliakou A, Castle D, Sallis H, Joseph C, O'Connor J, Wiffen B, Gayer-Anderson C, McQueen G, Taylor H, Bonaccorso S, Gaughran F, Smith S, Greenwood K, Murray RM, Di Forti M, Atakan Z, Ismail K. Reasons for cannabis use in first-episode psychosis: does strength of endorsement change over 12 months? Eur Psychiatry 2014; 30:152-9. [PMID: 25541346 DOI: 10.1016/j.eurpsy.2014.10.007] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/04/2014] [Revised: 10/29/2014] [Accepted: 10/29/2014] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND Why patients with psychosis use cannabis remains debated. The self-medication hypothesis has received some support but other evidence points towards an alleviation of dysphoria model. This study investigated the reasons for cannabis use in first-episode psychosis (FEP) and whether strength in their endorsement changed over time. METHODS FEP inpatients and outpatients at the South London and Maudsley, Oxleas and Sussex NHS Trusts UK, who used cannabis, rated their motives at baseline (n=69), 3 months (n=29) and 12 months (n=36). A random intercept model was used to test the change in strength of endorsement over the 12 months. Paired-sample t-tests assessed the differences in mean scores between the five subscales on the Reasons for Use Scale (enhancement, social motive, coping with unpleasant affect, conformity and acceptance and relief of positive symptoms and side effects), at each time-point. RESULTS Time had a significant effect on scores when controlling for reason; average scores on each subscale were higher at baseline than at 3 months and 12 months. At each time-point, patients endorsed 'enhancement' followed by 'coping with unpleasant affect' and 'social motive' more highly for their cannabis use than any other reason. 'Conformity and acceptance' followed closely. 'Relief of positive symptoms and side effects' was the least endorsed motive. CONCLUSIONS Patients endorsed their reasons for use at 3 months and 12 months less strongly than at baseline. Little support for the self-medication or alleviation of dysphoria models was found. Rather, patients rated 'enhancement' most highly for their cannabis use.
Collapse
Affiliation(s)
- A Kolliakou
- Department of Psychological Medicine, PO92, Institute of Psychiatry, King's College London, De Crespigny Park, SE5 8AF London, UK.
| | - D Castle
- Department of Psychiatry, University of Melbourne, Melbourne, Australia
| | - H Sallis
- MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, UK
| | - C Joseph
- Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK
| | - J O'Connor
- Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK
| | - B Wiffen
- Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK
| | - C Gayer-Anderson
- Department of Health Service and Population Research, Institute of Psychiatry, King's College London, London, UK
| | - G McQueen
- Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK
| | - H Taylor
- Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK
| | - S Bonaccorso
- Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK
| | - F Gaughran
- Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK
| | - S Smith
- Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, King's College London, London, UK
| | - K Greenwood
- School of Psychology, University of Sussex, Sussex, UK
| | - R M Murray
- Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK
| | - M Di Forti
- Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK
| | - Z Atakan
- Department of Neuroimaging, Institute of Psychiatry, King's College London, London, UK
| | - K Ismail
- Department of Psychological Medicine, PO92, Institute of Psychiatry, King's College London, De Crespigny Park, SE5 8AF London, UK
| |
Collapse
|
49
|
Joseph C, Finch C. Incidence of injury in community-level Australian Football: A national overview of insurance claims from 2004 to 2011. J Sci Med Sport 2014. [DOI: 10.1016/j.jsams.2014.11.382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
50
|
Joseph C, Morrissey D, Abdur-Rahman M, Hussenbux A, Barton C. Musculoskeletal triage: a mixed methods study, integrating systematic review with expert and patient perspectives. Physiotherapy 2014; 100:277-89. [PMID: 25242531 DOI: 10.1016/j.physio.2014.03.007] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2013] [Accepted: 03/03/2014] [Indexed: 11/29/2022]
Abstract
BACKGROUND Triage is implemented in healthcare settings to optimise access to appropriate care and manage waiting times. OBJECTIVES To determine the optimum features of triage systems for patients with musculoskeletal conditions. DATA SOURCES AMED, BNI, CINAHL, EMBASE, Health Business Elite, HMIC, MEDLINE, Cochrane Library, Web of Science and Google Scholar. STUDY SELECTION OR ELIGIBILITY CRITERIA Studies that included non-musculoskeletal conditions, concerned patients aged <18 years or were set in emergency departments were excluded. STUDY APPRAISAL AND SYNTHESIS METHODS Study quality was graded using the Downs and Black quality index. Qualitative methods were used to further inform the findings of the literature review. RESULTS Thirty-four studies met the inclusion criteria, with study quality ranging from eight to 24 out of a possible 27. Musculoskeletal triage is conducted via face-to-face consultation, paper referral letter or telephone consultation. Triage performed by physiotherapists, general practitioners, multidisciplinary teams, nurses, occupational therapists and speech therapists has been shown to be effective using a range of outcomes. Qualitative data revealed the value of supportive interdisciplinary teams, and suggested that this support is more important than choice of clinician. Patients trusted, and expressed preferences for, experienced clinicians to perform triage. CONCLUSION Triage can be performed effectively via a number of methods and by a range of clinicians. Satisfaction, cost, diagnostic agreement, appropriateness of referral and waiting list time have been improved though triage. Multidisciplinary support mechanisms are critical elements of successful triage systems. Patients are more concerned with access issues than professional boundaries.
Collapse
Affiliation(s)
- C Joseph
- Centre for Sports and Exercise Medicine, Bart's and the London School of Medicine and Dentistry, Queen Mary University of London, Mile End Hospital, London, UK; Clinical Research Centre for Movement Disorders and Gait, Southern Health Centre, Victoria, Australia
| | - D Morrissey
- Centre for Sports and Exercise Medicine, Bart's and the London School of Medicine and Dentistry, Queen Mary University of London, Mile End Hospital, London, UK; Physiotherapy Department, Bart's Health NHS trust, London, UK.
| | - M Abdur-Rahman
- Centre for Sports and Exercise Medicine, Bart's and the London School of Medicine and Dentistry, Queen Mary University of London, Mile End Hospital, London, UK
| | - A Hussenbux
- Centre for Sports and Exercise Medicine, Bart's and the London School of Medicine and Dentistry, Queen Mary University of London, Mile End Hospital, London, UK
| | - C Barton
- Centre for Sports and Exercise Medicine, Bart's and the London School of Medicine and Dentistry, Queen Mary University of London, Mile End Hospital, London, UK; Complete Sports Care, Melbourne, Victoria, Australia; Musculoskeletal Research Centre, La Trobe University, Bundoora, Victoria, Australia; Pure Sports Medicine, London, UK
| |
Collapse
|